Overview

Efficacy and Tolerability of Buscopan Plus in Painful Gastric or Intestinal Spasms

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to evaluate efficacy and tolerability of Buscopan® plus versus Buscopan®, paracetamol, and placebo in patients with painful gastric or intestinal spasms.
Phase:
Phase 2
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Acetaminophen
Butylscopolammonium Bromide
Scopolamine
Scopolamine Hydrobromide